The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Colombo, G.
Right arrow Articles by Catania, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Colombo, G.
Right arrow Articles by Catania, A.
The Journal of Immunology, 2005, 175: 3391-3401.
Copyright © 2005 by The American Association of Immunologists

Gene Expression Profiling Reveals Multiple Protective Influences of the Peptide {alpha}-Melanocyte-Stimulating Hormone in Experimental Heart Transplantation1

Gualtiero Colombo*, Stefano Gatti{dagger}, Flavia Turcatti*, Andrea Sordi*, Luigi R. Fassati{dagger}, Ferruccio Bonino{ddagger}, James M. Lipton§ and Anna Catania2,*

* Division of Internal Medicine, {dagger} Division of Liver Transplantation, and {ddagger} Scientific Direction, Fondazione Instituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milano, Italy; and § Zengen, Woodland Hills, CA 91367

Novel therapies are sought to increase efficiency and survival of transplanted organs. Previous research on experimental heart transplantation showed that treatment with the anti-inflammatory peptide {alpha}-melanocyte-stimulating hormone ({alpha}-MSH) prolongs allograft survival. The aim of the present research was to determine the molecular mechanism of this protective activity. Gene expression profile was examined in heart grafts removed on postoperative days 1 and 4 from rats treated with saline or the synthetic {alpha}-MSH analog Nle4DPhe7 (NDP)-{alpha}-MSH. On postoperative day 1, the peptide induced expression of cytoskeleton proteins, intracellular kinases, transcription regulators, metallopeptidases, and protease inhibitors. Conversely, NDP-{alpha}-MSH repressed immune, inflammatory, cell cycle, and protein turnover mediators. Later effects of {alpha}-MSH treatment included down-regulation of oxidative stress response and up-regulation of ion channels, calcium regulation proteins, phosphatidylinositol signaling system, and glycolipidic metabolism. NDP-{alpha}-MSH exerted its effects on both Ag-dependent and -independent injury. The results indicate that NDP-{alpha}-MSH preserves heart function through a broad effect on multiple pathways and suggest that the peptide could improve the outcome of organ transplantation in combination with immunosuppressive treatments.


Related articles in The JI:

IN THIS ISSUE

The JI 2005 175: 2767-2768. [Full Text]  



This article has been cited by other articles:


Home page
FASEB J.Home page
G. Leoni, H. B. Patel, A. L. F. Sampaio, F. N. E. Gavins, J. F. Murray, P. Grieco, S. J. Getting, and M. Perretti
Inflamed phenotype of the mesenteric microcirculation of melanocortin type 3 receptor-null mice after ischemia-reperfusion
FASEB J, December 1, 2008; 22(12): 4228 - 4238.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Catania
The melanocortin system in leukocyte biology
J. Leukoc. Biol., February 1, 2007; 81(2): 383 - 392.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.